TELIK, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 16239
 
  
 
C07K PEPTIDES 11125
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 7199
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 3135
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
B01D SEPARATION 2132
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 169

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8841476 Preparation of crystalline ezatiostat hydrochloride ansolvate form DApr 26, 11Sep 23, 14[A61K, C07C, C07K]
8759303 Compositions and methods for treating myelodysplastic syndromeMay 16, 11Jun 24, 14[A61K, A01N]
8716521 Formulations of canfosfamide and their preparationSep 14, 12May 06, 14[C07C]
8093231 Sulfonylethyl phosphorodiamidatesJul 17, 07Jan 10, 12[A61K, C07F]
7029695 Therapeutic compositions containing glutathione analogsJul 10, 01Apr 18, 06[A61K]
RE38915 Nonpeptide insulin receptor agonistsDec 21, 00Dec 06, 05[A61K]
6506739 Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agentsMay 01, 01Jan 14, 03[A61K, C07F, A61P]
6013462 Glutathione analogs as reagentsFeb 03, 97Jan 11, 00[G01N, C07K]
5955432 Metabolic effects of certain glutathione analogsJul 03, 96Sep 21, 99[A61K, C07K]
5851988 Nonpeptide insulin receptor agonistsJan 15, 97Dec 22, 98[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0329,754 COMPOSITIONS AND METHODS FOR TREATING MYELODYSPLASTIC SYNDROMEAbandonedApr 29, 14Nov 06, 14[A61K]
2013/0184,280 SUBSTITUTED THIAZOLES AS VEGFR2 KINASE INHIBITORSAbandonedDec 18, 12Jul 18, 13[C07D]
8481781 Formulations of canfosfamide and their preparationExpiredMar 22, 11Jul 09, 13[C07C]
8410163 Substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carbonitriles and substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carboxamides as tubulin polymerization inhibitorsExpiredFeb 09, 10Apr 02, 13[A61K, C07D]
2013/0035,389 METHODS FOR TREATING MYELODYSPLASTIC SYNDROME WITH EZATIOSTATAbandonedApr 02, 12Feb 07, 13[A61K, A61P, C40B]
8361971 Tablet formulation of ezatiostatExpiredSep 27, 11Jan 29, 13[A61K]
8324426 Formulations of canfosfamide and their preparationExpiredFeb 25, 11Dec 04, 12[C07C]
2012/0288,554 CANFOSFAMIDE MONOTHERAPY FOR TREATING MULTIPLE MYELOMAAbandonedMay 12, 11Nov 15, 12[A61K, C07F, A61P]
2012/0283,325 EXCIPIENT COMPATIBILITY WITH EZATIOSTATAbandonedApr 18, 12Nov 08, 12[A61K, A61P]
2012/0251,496 EZATIOSTAT FOR TREATING MULTIPLE MYELOMAAbandonedMar 20, 12Oct 04, 12[A61K, A61P]
2012/0165,260 CRYSTALLINE EZATIOSTAT HYDROCHLORIDE ANSOLVATEAbandonedMar 04, 11Jun 28, 12[A61K, A61P, C07K]
8207121 Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compoundExpiredOct 15, 07Jun 26, 12[C12N, G01N, A61P]
8198247 Process for and intermediates in the preparation of canfosfamide and its saltsExpiredDec 21, 04Jun 12, 12[A61K]
8129396 2-[1H-benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitorsExpiredSep 25, 09Mar 06, 12[C07D]
2011/0301,102 COMPOSITIONS AND METHODS FOR TREATING MYELODYSPLASTIC SYNDROMEAbandonedMay 16, 11Dec 08, 11[A61K, A61P]
2011/0301,199 COMPOSITIONS AND METHODS FOR TREATING MYELODYSPLASTIC SYNDROMEAbandonedMay 16, 11Dec 08, 11[A61K, A61P]
7872134 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidatesExpiredDec 12, 07Jan 18, 11[A61K, C07F]
2010/0056,825 Formulations of canfosfamide and their preparationAbandonedJul 29, 09Mar 04, 10[C07C]
7655799 2{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidatesExpiredNov 29, 06Feb 02, 10[A61K, C07F]
2008/0159,980 Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapyAbandonedOct 15, 07Jul 03, 08[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.